Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Lapatinib | 0.01 | uM | 7 | 625.00 | 98.92 | 2043.00 | 6877.50 | 0.2971 | 0.6402 |
| MCF 10A | 17-AAG | 0.031623 | uM | 7 | 625.00 | 98.92 | 161.00 | 6877.50 | 0.0234 | 0.0829 |
| MCF 10A | Lapatinib | 0.1 | uM | 7 | 625.00 | 98.92 | 4925.00 | 6877.50 | 0.7161 | 0.8938 |
| MCF 10A | Lapatinib | 0.031623 | uM | 7 | 625.00 | 98.92 | 6554.00 | 6877.50 | 0.9530 | 0.9843 |
| MCF 10A | Linsitinib | 3.1623 | uM | 7 | 625.00 | 98.92 | 2285.00 | 6877.50 | 0.3322 | 0.6704 |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 7992.00 | 6877.50 | 1.1621 | 1.0497 | |
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 625.00 | 98.92 | 6402.00 | 6877.50 | 0.9309 | 0.9767 |
| MCF 10A | Linsitinib | 0.31623 | uM | 7 | 625.00 | 98.92 | 5572.00 | 6877.50 | 0.8102 | 0.9324 |
| MCF 10A | Linsitinib | 0.1 | uM | 7 | 625.00 | 98.92 | 5912.00 | 6877.50 | 0.8596 | 0.9512 |
| MCF 10A | Erlotinib | 1 | uM | 7 | 625.00 | 98.92 | 659.00 | 6877.50 | 0.0958 | 0.3633 |
| MCF 10A | Linsitinib | 19.9526 | uM | 7 | 625.00 | 98.92 | 736.00 | 6877.50 | 0.1070 | 0.3881 |
| MCF 10A | Erlotinib | 0.031623 | uM | 7 | 625.00 | 98.92 | 7323.00 | 6877.50 | 1.0648 | 1.0206 |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 6550.00 | 6877.50 | 0.9524 | 0.9841 | |
| MCF 10A | 17-AAG | 3.1623 | uM | 7 | 625.00 | 98.92 | 218.00 | 6877.50 | 0.0317 | 0.1378 |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 7211.00 | 6877.50 | 1.0485 | 1.0155 | |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 4.00 | 6877.50 | 0.0006 | -0.4080 | |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 4.00 | 6877.50 | 0.0006 | -0.4080 | |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 6774.00 | 6877.50 | 0.9850 | 0.9951 | |
| MCF 10A | 17-AAG | 10 | uM | 7 | 625.00 | 98.92 | 203.00 | 6877.50 | 0.0295 | 0.1247 |
| MCF 10A | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 98.92 | 7403.00 | 6877.50 | 1.0764 | 1.0242 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 98.92 | 6548.00 | 6877.50 | 0.9521 | 0.9840 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 625.00 | 98.92 | 6877.00 | 6877.50 | 0.9999 | 1.0000 |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 8052.00 | 6877.50 | 1.1708 | 1.0522 | |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 625.00 | 98.92 | 448.00 | 6877.50 | 0.0651 | 0.2800 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 98.92 | 7264.00 | 6877.50 | 1.0562 | 1.0179 |